BIOC - Non-invasive. Simple blood test. Breast cancer most common cancer in women. All need to know hormone status for treatment. Someone diagnosed in US every 3 minutes.
Will see 10+ this week. 45 Million traded today. 80% above 4.50. Shorts trapped. IPO at 10.00 target 13.50. Shorts are going to push to 9+ this Friday.
The stock has a consensus analyst price target of $13.50
Read more: Biocept Breaks Through With Columbia Study (NASDAQ: BIOC) - 24/7 Wall St. http://247wallst.com/healthcare-business/2015/02/23/biocept-breaks-through-with-columbia-study/#ixzz3Sb0tuMkU
Follow us: @247wallst on Twitter | 247wallst on Facebook
some good size volume. Expect a 20 Million day and a spike in mid afternoon as this gets hot before Greek bailout tomorrow.